Human T Lypmphotrophic Virus (HTLV1) Related Diseases by Tabei, S Z
Iranian Red Crescent Medical Journal 
 
Iran Red Crescent Med J 2011; 13(6):374-376 ©Iranian Red Crescent Medical Journal 
EDITORIAL
Human T Lypmphotrophic Virus (HTLV1) Related 
Diseases 
 
 
By discovery of HTLV1 virus in 1898 as etiology of 
the diseases till present, they are considered as the 
first enemy of human being.
1 Today, advances in im-
munology have shown that the virus per se may not 
be the main cause of disease but the interaction be-
tween the virus and immune system is important in 
pathogenesis of the disease. For example in hepatitis 
B virus after entrance to the hepatocytes, three types 
of immune reactions may occur including: i). The 
severe attachment of T lymphocytes
2 to infected 
hepatocytes that would lead to necrosis and may result 
into an acute fulfillment of hepatitis, ii). A mild re-
spond of T lymphocytes with minimal injury to 
hepatocytes as a balance reaction of B lymphocyte 
would result into a mild hepatitis and nearly a perma-
nent immunity without any chronic disease or hepato-
cellular carcinoma and iii). Absence or presence of a 
minimal response that may be prone to hepatocellular 
carcinomas. 
Most treatment modalities are on a basis of suppress-
ing the immune response after administration of steroids 
or cytotoxic drugs. In the last twenty years, a correlation 
between psychology and immune system by the axis of 
hypothalamus was shown. Hypophysis and adrenal 
glands play an important role in psycho-neuro-
endocrino-immunology and treatment of the disease.
3 
The enigma of retrovirus which has a direct corre-
lation with immune system is another interesting 
point which I would like to discuss briefly here main-
ly in relation to two articles in the present issue of this 
journal. 
 
Biology of the Virus  
Human T Lypmphotrophic Virus (HTLV) from the 
family of retroviruses has been divided into three major 
types of I, II and III.
4 The structure as well as epidemi-
ology of the virus and related diseases have been inves-
tigated broadly in the last two decades, both in the world 
and also in Iran. HTLV1 is a 9 Kb Delta virus that could 
not be found in the serum of animal as well as human 
being. It has affinity to T lymphocyte,
5 monocytes, fi-
broblasts and synovial cells. So the transmission of the 
virus occurs by an infected cell.
6 Induction of lymphoma 
and leukemia by HTLV1 seems to happen by a tax pro-
tein.
7 The detail mechanism of cancer development 
could be found in literature.
8 
Epidemiology of the virus after that spread to sev-
eral areas of the world was considered as endemic 
regions for HTLV1.
9 Since most studies were under-
taken on blood donors of infected persons, the inci-
dence could not be easily determined. In Iran, the 
prevalence in northeast regions was shown to be 5% 
which is the highest endemic area in Iran.
10  
 
Routes of Transmission 
The transmission of the virus is vertically from 
mother to child by blood and milk and can be hori-
zontally by sexual contacts and transfusion of blood 
or contaminated needle stick too.
11 Sperm and milk 
can have infected lymphocyte and are important in 
transmission of the diseases from men to women and 
mother to child.
12  
 
Diseases Related to HTLV1 
The virus was shown to be a causative agent for 
several diseases including a) Adult T cell lymphoma 
leukemia,
13 b) Myelopathic spastic paraparesis,
14 c) 
Polymysitis
15 and d) Uveitis. The adult T cell lym-
phoma leukemia mostly occurs in adults and old age 
and is more common in women than men. The dis-
ease is presented by anemia, lymphadenopathy and 
hypercalcemia. The blast morphology is an especial 
indicator with a lobular or convoluted nucleus usually 
called flower cells.
16 Hypercalcemia vastly happens 
due to TGFB and IL1 which activates osteoclasts and 
also by PTHr in contaminated cells by HTLV1 too.
17 
Tropical paraparesis spastic (TSP) disease is patho-
logically an infiltration of mononuclear cells into the 
white matter,
18 degeneration of the Schwann cells and 
fibrosis of white matter.
19,20 
 
Prevention 
By considering that the diseases being related to 
HTLV1 as a chronic and devastating disease, the pre-
vention is important by screening of the blood donors 
as well as mothers for presence of any antibody 
against HTLV1 in endemic areas that has an im-
portant role in prevention of the disease.  HTLV1 related diseases 
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As one of the ways of transmission is by sexual 
route, mass media education would be important 
identically done for HIV infection. In Iran, for the 
first time in 1986, we reported two patients with leu-
kemia from Mashhad in Northeast part of Iran pre-
sented with 80% of convoluted blasts in the bone 
marrow accompanied with hypercalcemia.
21 Although 
at that time, no virology test was available, by con-
sidering blast morphology and hypercalcemia, we 
thought that the disease may have a correlation with 
HTLV 1 infection.  
In 1992, Sid et al.,
22 also reported four cases who 
had immigrated from Mashhad to Telaviv and had a 
positive serology to HTLV1. Two more patients from 
Mashhad with the diagnosis of multiple sclerosis 
were shown to be positive for HTLV1 antibody.
23 So, 
HTLV1 infection was shown to be endemic in Khora-
san Province in northeast of Iran. Several surveys by 
our colleagues in Mashhad University of Medical 
Sciences confirmed the matter. A survey on blood 
donors in Khorasan Province and other provinces in 
the country showed infection in blood samples in 
Khorasan and other provinces.
24 
In several studies from Iran and Middle East, the high 
seropositivity with HTLV1 was demonstrated. The 
retrovirus HTLV I, II and III infections are all tropic 
to T lymphocytes and microglial cells. Therefore, the 
immune system in establishment and progress of the 
diseases and the effect of psychology on the immune 
system were emphasized. 
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